52 /100
HIGH RISK
Score updated Jul 13, 2026

SRPT — Sarepta Therapeutics, Inc. Dilution Risk Tracker

Track SRPT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SRPT — Get alerts when the score changes →

As of July 13, 2026, Sarepta Therapeutics, Inc. (SRPT) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Sarepta Therapeutics, Inc. has a market capitalization of $1.89B, 105.58M shares outstanding, 344 institutional holders tracked. Key dilution vectors include approximately 6 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
34%
🔁 Convertible Conversion 60%
• Major convertible overhang: 30% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 15%
• Under 12 months cash (6mo)
🔔 Track SRPT — Get forecast alerts →

💹 Market Data

Market Cap$1.89B
Shares Outstanding105.58M
Float94.80M
Cash$653.19M
Debt$1.45M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 21.9% shares (2026Q1 vs prior)
344 institutional holders · 127.57M shares
#1 BlackRock, Inc. 14.76M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 9.16M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 6.64M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest28.73M
Days to Cover5.8
% of Float30.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for SRPT Shareholders

Sarepta Therapeutics, Inc. (SRPT) has a DilutionScore of 52/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: SRPT has approximately 6 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for SRPT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SRPT alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track SRPT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SRPT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SRPT
📊 SRPT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SRPT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.